Breast Cancer: Overview & Updates

Overview

Journal Nurse Pract

Specialty Nursing

Date 2011 Nov 18

PMID 22089837

Citations 22

Authors

Catherine Downs-Holmes

Paula Silverman

Affiliations

Soon will be listed here.

Abstract

Breast cancer is a complex disease and treatment recommendations are continually changing. It is the leading cancer in women and the second leading cause of cancer mortality. This overview of breast cancer will discuss pathologic features, local and systemic treatment considerations, endocrine therapy, metastatic treatment regimens, and follow-up for optimal breast health. Recent approvals that advance the treatment of metastatic breast cancer are also addressed.

Citing Articles

Effective Ki-67 Reduction by Pre-Surgery Short-Term Administration of Letrozole in (Hormone-Positive) Breast Cancer.

Eslami B, Alipour S, Golfam F, Jahabnin B, Omranipour R Iran J Pathol. 2024; 19(1):103-106.

PMID: 38864079 PMC: 11164301. DOI: 10.30699/IJP.2023.2002772.3118.

miRNAs: Potential as Biomarkers and Therapeutic Targets for Cancer.

Chakrabortty A, Patton D, Smith B, Agarwal P Genes (Basel). 2023; 14(7).

PMID: 37510280 PMC: 10378777. DOI: 10.3390/genes14071375.

Evaluation of the Anticancer Activity of Calcium Ions Introduced into Human Breast Adenocarcinoma Cells MCF-7/WT and MCF-7/DOX by Electroporation.

Biezunska-Kusiak K, Kulbacka J, Choromanska A, Rembialkowska N, Michel O, Saczko J Pharmaceuticals (Basel). 2023; 16(6).

PMID: 37375757 PMC: 10304440. DOI: 10.3390/ph16060809.

Identification and validation of a prognostic risk model based on caveolin family genes for breast .

Tang Q, Wang S, Di Z, Li H, Xu K, Hu X Front Cell Dev Biol. 2022; 10:822187.

PMID: 36147736 PMC: 9485841. DOI: 10.3389/fcell.2022.822187.

Evaluation of miR-34a Effect on CCND1 mRNA Level and Sensitization of Breast Cancer Cell Lines to Paclitaxel.

Irani S, Paknejad M, Soleimani M, Azam S Iran Biomed J. 2020; 24(6):361-9.

PMID: 32660221 PMC: 7601542. DOI: 10.29252/ibj.24.6.356.